Poland· PL-100346913
Duloxetine Sandoz
A duloxetine product containing duloxetinum, registered in Poland by Sandoz GmbH. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Duloxetine is registered in 16 of 19 countries.
Countries holding a registration under ATC N06AX21 (duloxetine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Duloxetine · ATC N06AX21
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of duloxetine costs, country by country.
Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.28 in United States to $1.57 in Switzerland — a ×5.6 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Duloxetine · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.57
- IT Italy$0.67
- US United States$0.28 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Duloxetinum
- Manufacturer
- Sandoz GmbH
- Country
- Poland (PL)
- ATC code
- N06AX21
- ATC class
- Duloxetine
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 8
- gtin05909991265243
- gtin05909991265250
- gtin05909991265267
- gtin05909991265274
- gtin05909991265281
- gtin05909991265298
- gtin05909991265304
- gtin05909991265311
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
501 interactions on record for duloxetine.
Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Duloxetine · interactions on record
501 records
- 33 severe
- 247 moderate
- 23 minor
- 130 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
68 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Duloxetine in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCymbaltaEli Lilly and Company
- SpainCYMBALTA 60 MG CAPSULAS DURAS GASTRORRESISTENTESEli Lilly Nederland B.V.
- United KingdomCymbalta 60mg gastro-resistant capsulesPilsco Ltd
- ItalyALIKRESLABORATORIO FARMACEUTICO C.T. S.R.L.
- CanadaACCEL-DULOXETINEACCEL PHARMA INC
- NetherlandsCymbalta 60 mg, maagsapresistente capsules, hardEli Lilly Nederland BV
- SwedenAritavi 60 mg Enterokapsel, hårdTeva B.V.
- BelgiumAriclaim 60 mgEli Lilly Nederland
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Dulasolan, Duloxetin +pharma
- Belgium · Duloxetin Ab, Duloxétine Ab
- Bulgaria · Dulasolan, Duxet
- Cyprus · Dulox, Duloxetine Accord
- Czechia · Dolyxan, Dulasolan
- Germany · Dulasolan, Duloxalta
- Denmark · Aritavi, Duciltia
- Estonia · Dulsevia, Onelar
- Spain · Dedulox 30 Mg Cápsulas Duras Gastrorresistentes Efg, Dedulox 60 Mg
- Finland · Duloxetin Stada, Duloxetine Accord
- France · Duloxetine Accord, Duloxetine Almus
- United Kingdom (Northern Ireland) · Depalta, Duciltia
- Greece · Duciltia, Duloxetine Liconsa
- Croatia · Dolyxan, Duloksetin Pliva
- Hungary · Duciltia, Dulodet
- Ireland · Duloxetine Accord, Duloxetine Clonmel
- Iceland · Aritavi, Cymbalta
- Italy · Alikres, Dulex
- Liechtenstein · Cymbalta, Duloxetine Lilly
- Lithuania · Dulsevia
- Luxembourg · Duloxetin Ab, Duloxetine Liconsa
- Latvia · Dulsevia
- Malta · Onelar
- Netherlands · Dulasolan, Dulodet
- Norway · Cymbalta, Duloxetin Krka
- Portugal · Duloxetina Alter, Duloxetina Amperlem
- Romania · Dozzex, Duloxetină Dr. Reddy's
- Sweden · Aritavi, Dulmis
- Slovenia · Duloksetin Sandoz, Dulsevia
- Slovakia · Duloxetin Krka, Duloxetin Krka, D.D., Novo Mesto
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cefe0be3-d25d-4b4b-a985-91683808e45a GET /v1/drugs/cefe0be3-d25d-4b4b-a985-91683808e45a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki dojelitowe, twarde",
"source": "urpl",
"strength": "60 mg",
"packaging": "05909991265243 ¦ Rp ¦ 114517\n7 kaps.\n05909991265250 ¦ Rp ¦ 114518\n14 kaps.\n05909991265267 ¦ Rp ¦ 114519\n28 kaps.\n05909991265274 ¦ Rp ¦ 114520\n30 kaps.\n05909991265281 ¦ Rp ¦ 114521\n50 kaps.\n05909991265298 ¦ Rp ¦ 114522\n56 kaps.\n05909991265304 ¦ Rp ¦ 114523\n84 kaps.\n05909991265311 ¦ Rp ¦ 114524\n98 kaps.",
"substance": "Duloxetini hydrochloridum 60 mg",
"common_name": "Duloxetinum",
"pl_product_id": "100346913",
"pozwolenie_nr": "23030",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about duloxetine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.